Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: Comparison between Lewis and Wistar rats

Molecular and Cellular Endocrinology

Volumn 199, Issue 1-2, 2003, Pages 23-28

  Priego, T ^a   Ibanez De Caceres I ^a   Martin A I ^b   Villanua M A ^a   Lopez Calderon A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

IGFBP 3; Lewis rats; Liver IGFBP 3 mRNA; LPS; Serum IGFBP 3 proteolysis; Wistar rats

Indexed keywords

ENDOTOXIN; GROWTH HORMONE; LIPOPOLYSACCHARIDE; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATION; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RAT STRAIN; STRAIN DIFFERENCE;

ANIMALS; ENDOPEPTIDASES; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LIPOPOLYSACCHARIDES; LIVER; MALE; RATS; RATS, INBRED LEW; RATS, WISTAR; RNA, MESSENGER;

EID: 0037474112     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00356-8     Document Type: Article

References (29)

1. Albiston A.L., Herington A.C. Cloning and characterization of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat. Biochem. Biophys. Res. Commun. 166:1990;892-897.
2. Benbassat C.A., Lazarus D.D., Cichy B., Evans T.M., Moldawer L.L., Lowry S.F., et al. Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro. Horm. Metab. Res. 31:1999;209-215.
3. Bohé J., Ding H., Qing D.P., Yoon K., Hirschberg R., Wolgang G.H.I., et al. IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I. Kidney Int. 54:1998;1070-1082.
4. Conover C.A., Ronk M., Lombana F., Powell D.R. Structural and biological characterization of bovine insulin-like growth factor protein-3. Endocrinology. 127:1990;2796-2803.
5. Davies S.C., Wass J.A.H., Ross R.J.M., Cotterill A.M., Buchanan C.R., Coulson V.J., et al. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J. Endocrinol. 130:1991;469-473.
6. Elgin R.G., Busby W.H. Jr, Clemmons D.R. An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proc. Natl. Acad. Sci. 84:1987;254-258.
7. Fan J., Molina P.E., Gelato M.C., Lang C.H. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology. 134:1994;1685-1692.
8. Hochscheid R., Jaques G., Wegmann B. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. J. Endocrinol. 166:2000;553-563.
9. Ibáñez de Cáceres I., Villanúa M.A., Soto L., Martín A.I., López-Calderón A. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. J. Endocrinol. 165:2000;537-544.
10. Ibáñez de Cáceres I., Holly J.M.P., Martín A.I., López-Calderón A., Villanúa M.A. Arthritis-induced increase in serum levels of IGFBP-3 in rats is secondary to the decrease in its proteolytic activity. J. Endocrinol. 173:2002;357-364.
11. Katsanos K., Tsatsoulis A., Christodoulos D., Challa A., Katsaraki A., Tsianos V. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm. IGF Res. 11:2001;364-367.
12. Katz, J., Weiss, H., Goldman, B., Kanety, H., Stannard, B., LeRoith, D, Shemer, J., 1995. Cytokines and growth factors modulate cell growth and insulin-like growth factor binding protein secretion by the human salivary cell line. J. Cell. Physiol. 165, 223-237.
13. Lamson G., Giudice L.C., Rosenfeld R.G. A simple assay for the proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3). J. Clin. Endocr. Metab. 72:1991;1391-1394.
14. Lang C.H., Liu X., Nystrom G.J., Frost R.A. Acute response of IGF-I and IGF-I binding proteins induced by thermal injury. Am. J. Physiol. Endocrinol. Metab. 278:2000;1087-1096.
15. Lang C.H., Nystrom G.J., Frost R.A. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNF. Growth Horm. IGF Res. 11:2001;250-260.
16. Lelbach A., Scharf J.-G., Ramadori G. Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by interleukin-6. J. Hepatol. 35:2001;558-567.
17. López-Calderón A., Soto L., Martín A.I. Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats. Life Sci. 65:1999;2049-2060.
18. Moberg G.P. Site of action of endotoxins on hypothalamic-pituitary-adrenal axis. Am. J. Physiol. 220:1971;397-400.
19. Priego T., Ibáñez de Cáceres I., Martín A.I., Villanúa M.A., López-Calderón A. Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum insulin-like growth factor (IGF)-I and hepatic IGF-I messenger RNA. J. Endocrinol. 172:2002;449-456.
20. Rodríguez-Arnao, J., Yarwood, G., Ferguson, C., Miell, J., Hins, C.J., Ross, R.J.M., 1996. Reduction in circulating IGF-I and hepatic IGF-I mRNA levels after caecal ligation and puncture are associated with differential regulation of hepatic IGF-binding protein-1, -2 and -3 mRNA levels. J. Endocrinol. 151, 287-292.
21. Roubenoff R., Freeman L.M., Smith D.E., Abad L.W., Dinarello C.A., Kehayias J.J. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 40:1997;534-539.
22. Rozen F., Zhang J., Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int. J. Oncol. 13:1998;865-869.
23. Scharf J.G., Ramadori G., Braulke T., Hartmann H. Synthesis of insulinlike growth factor binding protein and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor and growth hormone. Hepatology. 23:1996;818-827.
24. Scharf J.-G., Knittel T., Dombrowski F., Müller L., Saile B., Braulke T., Hartmann H., Ramadori G. Characterization of the IGF axis components in isolated rat hepatic stellae cells. Hepatology. 27:1998;1275-1284.
25. Skjaerbaek C., Frystyk J., Orskov H., Kissmeyer-Nielsen P., Jensen M.B., Laurberg S., Mollern N., Flybjerg A. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolyisis. J. Clin. Endocrinol. Metab. 83:1998;2445-2449.
26. Soto L., Martín A.I., Millán S., Vara E., López-Calderón A. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. J. Endocrinol. 59:1998;239-246.
27. Thomas F.M., Knowles S.E., Owens P.C., Chandler C.S., Francis G.L., Read L.C., Ballard F.J. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem. J. 282:1992;91-97.
28. Villafuerte B.C., Zhang W.N., Phillips L.S. Insulin and insulin-like growth factor-I regulate hepatic insulin-like growth factor binding protein-3 by different mechanism. Mol. Endocrinol. 10:1996;622-630.
29. Whellams E.J., Maile L.A., Fernihough J.K., Billigham M.E.J., Holly J.M.P. Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint. J. Endocrinol. 165:2000;545-556.